Daniel N. Klein, PhD
- 7Articles
- 29.7KReads1
- 1998–2022Active
- 34Collaborators
- 189Citations2
About
Daniel N. Klein, PhD, affiliated with Stony Brook University in Stony Brook, New York, has published extensively on depression, particularly major depressive disorder (MDD), and child and adolescent psychiatry. His work includes studies on antidepressant treatments, such as sertraline, imipramine, and nefazodone, as well as psychotherapy approaches like the Cognitive Behavioral Analysis System of Psychotherapy. He has also investigated psychometric assessments related to irritability in children and the side effects of antidepressant treatments in patients with comorbid panic disorder. Klein's research spans from 1998 to 2022 and has appeared in Psychiatrist.com journals.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
